US BANCORP \DE\ - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 242 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$228,233
-51.2%
28,458
-9.8%
0.00%
-100.0%
Q1 2024$467,675
+289.8%
31,557
+113.8%
0.00%
Q4 2023$119,974
+474.8%
14,757
+221.7%
0.00%
Q3 2023$20,871
-46.1%
4,587
-16.6%
0.00%
Q2 2023$38,698
+13.3%
5,497
-1.7%
0.00%
Q1 2023$34,161
+65.1%
5,591
+72.7%
0.00%
Q4 2022$20,685
-13.8%
3,237
+29.1%
0.00%
Q3 2022$24,000
-45.5%
2,507
-37.3%
0.00%
Q2 2022$44,000
-18.5%
3,999
+22.2%
0.00%
Q1 2022$54,000
-34.1%
3,273
-24.0%
0.00%
Q4 2021$82,000
-60.8%
4,308
-49.3%
0.00%
Q3 2021$209,000
+39.3%
8,489
+48.4%
0.00%
Q2 2021$150,000
+10.3%
5,722
+32.7%
0.00%
Q1 2021$136,000
-85.9%
4,312
-79.2%
0.00%
-100.0%
Q4 2020$964,000
+129.5%
20,773
+63.0%
0.00%
+100.0%
Q3 2020$420,000
+324.2%
12,748
+255.1%
0.00%
Q2 2020$99,000
-10.0%
3,590
-2.7%
0.00%
Q1 2020$110,000
+89.7%
3,688
+74.7%
0.00%
Q4 2019$58,000
+152.2%
2,111
+72.3%
0.00%
Q3 2019$23,0000.0%1,225
+31.6%
0.00%
Q2 2019$23,0009310.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,019,201$26,720,00020.38%
Broadfin Capital, LLC 5,951,153$52,668,0006.92%
GREAT POINT PARTNERS LLC 5,567,348$49,271,0006.23%
Avoro Capital Advisors LLC 10,261,039$90,810,0005.43%
FRAZIER MANAGEMENT LLC 2,188,331$19,367,0005.00%
Prosight Management, LP 1,062,500$9,403,0004.85%
Perceptive Advisors 12,241,111$108,333,0004.12%
Ghost Tree Capital, LLC 1,000,000$8,850,0003.21%
QVT Financial LP 1,021,361$8,696,0002.84%
Vivo Capital, LLC 1,600,000$14,160,0001.81%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders